BVF I GP LLC, Director, 10% Owner at MoonLake Immunotherapeutics (MLTX), sold 2,000,000 shares at $50.00 ($100.0M) on 2024-10-04, disclosed to the SEC on 2024-10-08.
Open-market sale of $100.0M MLTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 132,549 | $6.6M | 6.6% |
| 2 | $50.00 | 836,862 | $41.8M | 41.8% |
| 3 | $50.00 | 1,030,589 | $51.5M | 51.5% |
| Total | $50.00 avg | 2,000,000 | $100.0M | 100% |
| Filing → |
| MRUS | SELL | 2021-07-07 | $90.7M | — | Filing → |
| RAIN | BUY | 2021-05-20 | $5.6M | — | Filing → |
| MRUS | BUY | 2020-09-08 | $4.5M | — | Filing → |